Kezar Life Sciences Inc.

5.04
-0.13 (-2.51%)
At close: Mar 27, 2025, 3:59 PM
5.30
5.20%
After-hours: Mar 27, 2025, 07:56 PM EDT

Kezar Life Sciences Income Statement

Year FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16
Revenue n/a 7M n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue n/a 1.07M 1.02M 1.51M 1.54M 1.3M 690K 175K 154K
Gross Profit n/a 5.93M -1.02M -1.51M -1.54M -1.3M -690K -175K -154K
Operating Income -90.61M -105.24M -71.16M -54.66M -42.95M -37.34M -24.73M -8.75M -8.99M
Interest Income 8.46M 11.1M 4.11M 188K 1.21M 2.25M 1.56M 232K n/a
Pretax Income -83.74M -101.87M -68.24M -54.63M -41.74M -35.09M -23.17M -8.52M -8.99M
Net Income -83.74M -101.87M -65.32M -53.28M -38.99M -31.53M -23.17M -8.52M -8.99M
Selling & General & Admin 23.39M 26.54M 20.15M 15.72M 11.97M 9.98M 6.59M 2.28M 1.62M
Research & Development 65.74M 85.7M 51.01M 38.94M 30.98M 27.36M 18.14M 6.47M 7.37M
Other Expenses 1.47M 6.19M n/a n/a n/a n/a n/a n/a n/a
Operating Expenses 90.61M 118.42M 71.16M 54.66M 42.95M 37.34M 24.73M 8.75M 8.99M
Interest Expense -1.59M 1.55M 1.19M 159K n/a n/a n/a n/a n/a
Selling & Marketing Expenses n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses n/a 112.24M 71.16M 54.66M 42.95M 37.34M 24.73M 8.75M 8.99M
Income Tax n/a n/a -2.92M -1.35M -2.75M -3.56M 1.56M n/a n/a
Shares Outstanding (Basic) 72.9M 72.55M 67.37M 52.76M 44M 19.08M 10.26M 13.02M 13.02M
Shares Outstanding (Diluted) 72.9M 72.55M 67.37M 52.76M 44M 19.08M 10.26M 13.02M 13.02M
EPS (Basic) -1.15 -1.4 -0.97 -1.01 -0.89 -1.65 -2.26 -0.65 -0.69
EPS (Diluted) -1.15 -1.4 -0.97 -1.01 -0.89 -1.65 -2.26 -0.65 -0.69
EBITDA -90.61M -99.25M -66.11M -52.96M -40.26M -34.42M -22.48M -8.34M -8.84M
Depreciation & Amortization n/a 1.07M 1.02M 1.51M 1.54M 1.3M 690K 175K 154K